Bicara Therapeutics Inc. trailing returns
How Bicara Therapeutics Inc. (BCAX) has performed over the last day, week, month and year and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +5.0% | +0.0% | +5.0% | — |
| 5 days | +5.8% | +0.0% | +5.8% | -4.8%Oct 16 |
| 1 month | -18.9% | +0.0% | -18.9% | -27.9%Oct 7 |
| YTD | +9.0% | +0.0% | +9.0% | -46.0%Oct 7 |
| 1 year | +12.9% | +0.0% | +12.9% | -46.0%Oct 2026 |
| Since inception (2024) | -10.9% | +0.0% | -10.9%-21.6% | -67.8%Jun 2025 |
Growth of BCAX#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- Since inception (2024)-10.9%/year · -21.6%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in BCAX's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Bicara Therapeutics Inc.'s return since inception?
- Since 2024, Bicara Therapeutics Inc. (BCAX) has compounded at about -10.9% a year — -21.6% in total.